Cite
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques.
MLA
King, Hannah A. D., et al. “Efficacy and Breadth of Adjuvanted SARS-CoV-2 Receptor-Binding Domain Nanoparticle Vaccine in Macaques.” Proceedings of the National Academy of Sciences of the United States of America, vol. 118, no. 38, Sept. 2021. EBSCOhost, https://doi.org/10.1073/pnas.2106433118.
APA
King, H. A. D., Joyce, M. G., Lakhal-Naouar, I., Ahmed, A., Cincotta, C. M., Subra, C., Peachman, K. K., Hack, H. R., Chen, R. E., Thomas, P. V., Chen, W.-H., Sankhala, R. S., Hajduczki, A., Martinez, E. J., Peterson, C. E., Chang, W. C., Choe, M., Smith, C., Headley, J. A., … Bolton, D. L. (2021). Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques. Proceedings of the National Academy of Sciences of the United States of America, 118(38). https://doi.org/10.1073/pnas.2106433118
Chicago
King, Hannah A D, M Gordon Joyce, Ines Lakhal-Naouar, Aslaa Ahmed, Camila Macedo Cincotta, Caroline Subra, Kristina K Peachman, et al. 2021. “Efficacy and Breadth of Adjuvanted SARS-CoV-2 Receptor-Binding Domain Nanoparticle Vaccine in Macaques.” Proceedings of the National Academy of Sciences of the United States of America 118 (38). doi:10.1073/pnas.2106433118.